tiprankstipranks
NLS Pharmaceutics Ltd. Addresses Financial Claims
PremiumCompany AnnouncementsNLS Pharmaceutics Ltd. Addresses Financial Claims
1M ago
NLS Pharmaceutics announces $1.75M registered direct offering
PremiumThe Fly
NLS Pharmaceutics announces $1.75M registered direct offering
1M ago
NLS Pharmaceutics Expands Neurological Therapy Options
PremiumCompany Announcements
NLS Pharmaceutics Expands Neurological Therapy Options
1M ago
NLS Pharmaceutics receives notice of deficiency from Nasdaq
PremiumThe FlyNLS Pharmaceutics receives notice of deficiency from Nasdaq
4M ago
NLS Pharmaceutics enters exclusive option agreement with Aexon Labs
PremiumThe Fly
NLS Pharmaceutics enters exclusive option agreement with Aexon Labs
5M ago
NLS Pharmaceutics elects Florence Allouche Aknin, Claudio Basetti to board
PremiumThe Fly
NLS Pharmaceutics elects Florence Allouche Aknin, Claudio Basetti to board
5M ago
NLS Pharmaceutics CEO says ‘making significant progress’ on 2023 objectives
PremiumThe FlyNLS Pharmaceutics CEO says ‘making significant progress’ on 2023 objectives
8M ago
NLS Pharmaceutics to host business news update conference call
PremiumThe Fly
NLS Pharmaceutics to host business news update conference call
10M ago
NLS Pharmaceutics to host business news update conference call
PremiumThe Fly
NLS Pharmaceutics to host business news update conference call
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100